An update to our reporting on recently-approved Alzheimer’s drugs. You may recall FDA advisers and many independent watchdogs said there’s no good evidence the hugely expensive shots make a meaningful difference, and they could cause serious side effects. But the […]
The biggest new hope for a blockbuster drug to cure Alzheimer’s has been mired in controversy ever since it went to market. Critics say it’s a sign of declining standards and conflicts of interest at the FDA. And now, the
Dr. Martin Makary of Johns Hopkins has straight talk on why so many public health officials avoided talking about natural immunity, and what’s happened to science in this conflicted and managed information environment.
If you’ve heard of Sturgis, South Dakota, it’s probably because of its annual motorcycle rally. In 2020, Sturgis made headlines for hosting the famous affair while much of America was shut down. Today, we head to Sturgis off-season, to find
WATCH: Was Sturgis 2020 the deadly super-spreader event it was made out to be? No. Read More »
